DUBLIN–(BUSINESS WIRE)–The “Global Artificial Intelligence of Things (AIoT) in Telecommunications Growth Opportunities” report has been…
Offers fast-track automation across 20+ channels in voice and chat with 360-degree Customer Engagement SAN…
Adept is building a natural language interface to everyday software tools SAN FRANCISCO–(BUSINESS WIRE)–Adept, a…
AUSTIN, Tex., April 26, 2022 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing…
Seamless, Comprehensive Capabilities Eliminate Barriers to Microbiome Research RENSSELAER, N.Y., April 26, 2022 (GLOBE NEWSWIRE)…
Company continues innovating preclinical tools used in new and ongoing small animal research and product…
DUBLIN, Ireland and BRIDGEWATER, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
GB0139 is Galecto’s proprietary inhaled once-daily small molecule galectin-3 inhibitor GALACTIC-1 trial on track to…
Conference Call on Tuesday, May 10, 2022 at 8:30 a.m. ET LEXINGTON, Mass., April 26,…
FREMONT, CA, April 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
BASEL, Switzerland, April 26, 2022 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) today announced it will…
Physicians To Have Pre-Approval/Expanded Access to Galinpepimut-S (GPS) for Treatment of Patients with Acute Myeloid…
MINNEAPOLIS, April 26, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical…
IRVINE, Calif., April 26, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…
POINT Biopharma’s Phase 3 SPLASH trial in pre-chemo metastatic castration-resistant prostate cancer (mCRPC) is now…
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice”…
JERSEY, Channel Islands, April 26, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage…
Gastric cancer is the third most common cause of cancer related death in the world…